Metropolitan Life Insurance Company (MetLife)’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,286
| Closed | -$21.9K | – | 410 |
|
|
2024
Q1 | $21.9K | Hold |
1,286
| – | – | ﹤0.01% | 1811 |
|
|
2023
Q4 | $13.1K | Hold |
1,286
| – | – | ﹤0.01% | 2085 |
|
|
2023
Q3 | $11.6K | Hold |
1,286
| – | – | ﹤0.01% | 2149 |
|
|
2023
Q2 | $13.8K | Sell |
1,286
-503
| -28% | -$5.41K | ﹤0.01% | 2122 |
|
|
2023
Q1 | $18.3K | Sell |
1,789
-197
| -10% | -$2.02K | ﹤0.01% | 1925 |
|
|
2022
Q4 | $21K | Buy |
1,986
+156
| +9% | +$1.65K | ﹤0.01% | 1984 |
|
|
2022
Q3 | $23.5K | Hold |
1,830
| – | – | ﹤0.01% | 1951 |
|
|
2022
Q2 | $23.5K | Hold |
1,830
| – | – | ﹤0.01% | 1967 |
|
|
2022
Q1 | $19.2K | Sell |
1,830
-5,590
| -75% | -$58.5K | ﹤0.01% | 2117 |
|
|
2021
Q4 | $114K | Hold |
7,420
| – | – | ﹤0.01% | 2395 |
|
|
2021
Q3 | $167K | Buy |
7,420
+2,418
| +48% | +$54.6K | ﹤0.01% | 2208 |
|
|
2021
Q2 | $129K | Buy |
5,002
+545
| +12% | +$14K | ﹤0.01% | 2454 |
|
|
2021
Q1 | $186K | Buy |
+4,457
| New | +$186K | ﹤0.01% | 2071 |
|